VIPOS 2026 brought together more than 250 oncology specialists in Chennai to discuss advances in precision medicine, targeted therapies and multidisciplinary approaches that are shaping personalised cancer care.
More than 250 oncology specialists from India and abroad gathered in Chennai for the three day summit organised by VS Hospitals and VS Medical Trust to discuss advances in molecular diagnostics, targeted therapies and multidisciplinary cancer treatment.
More than 250 oncologists, surgeons, radiation specialists and researchers from India and overseas gathered in Chennai for the VS International Precision Oncology Summit 2026 to discuss emerging developments in personalised cancer care.
The three day summit, organised by VS Hospitals and VS Medical Trust under the theme “Precision Meets Progress”, focused on advances in precision oncology, including molecular diagnostics, genomics, targeted therapies and multidisciplinary treatment approaches aimed at improving patient outcomes.
Experts at the conference discussed how precision oncology is moving cancer care beyond conventional treatment models by enabling therapies tailored to the biological characteristics of individual patients.
The scientific programme covered topics including advanced molecular diagnostics, immunotherapy, targeted therapies, precision radiation techniques, minimally invasive and robotic surgery, organ preservation strategies, multidisciplinary tumour boards and evidence based treatment planning. Faculty members also presented complex clinical cases and shared international experiences in cancer management.
Padma Shri Dr. Ravi Kannan, Director, Cachar Cancer Hospital and Research Center, Assam, who attended as Chief Guest, said precision oncology has become increasingly important for cancer care in India and emphasised that scientific advances should ultimately improve patient care.
Prof. Dr. S. Subramanian, Programme Director and Organising Chairperson of VIPOS 2026, said, “Precision Oncology allows us to understand the unique biology of every patient’s tumour and enable us to deliver more targeted therapies with lesser side effects. VIPOS is a platform accelerating the adoption of these advances and ensuring that patients benefit from the latest evidence based innovations.”
Prof. Dr. S. Sundar, Medical Director, VS Group of Hospitals, said, “Such academic initiatives like the VIPOS, strengthen the exchange of knowledge among healthcare professionals and enable them to adopt cutting edge technologies that translate into better treatment outcomes and improved quality of life for patients.
S. Muthu Subramanian, Executive Director, VS Group of Hospitals, said, “VS Hospitals continues to strengthen its commitment to advancing oncology by fostering clinical excellence, research, innovation and global collaborations while bringing in latest advancements in precision cancer care closer to patients.”
The summit featured scientific sessions, keynote lectures, panel discussions and multidisciplinary case based discussions covering breast, lung, gastrointestinal, gynaecological, head and neck, genitourinary and haematological cancers, along with precision radiation oncology.
The event was organised under the leadership of Dr. Vijay, Organising Secretary of VIPOS 2026, with guidance from Prof. Dr. S. Subramanian and support from Prasanna Srinivasan, Group Chief Operating Officer, VS Group of Hospitals.
At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.
About Prittle Prattle News
Prittle Prattle News is a digital news publication covering business, technology, healthcare, education, lifestyle, public affairs and other developments from India and around the world. Led by Editor-in-Chief Smruti Bhalerao, we publish timely news, industry updates and feature stories for a broad readership.
Add Comment